App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
ConditionObstructive Sleep Apnea
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night for 6 nights per week for people who have OSA with the help of a smartphone application called SmartWell24. This application aims to target CPAP adherence.
Eligibility criteria
Qualifiers
In both trials of Aim 2, twenty adults (≥18 years) per trial will be recruited who are newly diagnosed with OSA and speak English.
In both trials, we will purposely recruit samples balanced by biological sex and OSA severity (apnea hypopnea index: 5-14 vs. ≥ 15).
Are diagnosed with OSA based on clinical diagnostic testing via laboratory or home-based sleep study;
Own and have the functional and cognitive ability to use an Apple (iOS9 or higher) or Android (4.2 or higher) smartphone with minimal to no assistance;
Disqualifiers
Unwilling to complete study measures and engage with SleepWell24;
Refuse to not use the Fitbit application during the study trial;
Have any conditions that would impede full participation (e.g., communication or cognitive impairments that limit ability to read and/or follow directions, other acute or severe health, cognitive, or psychological conditions);
Currently participating in other lifestyle programs (e.g. active, formal weight loss program or research study; smoking cessation program, etc.);
Trial design
Treatments tested in this trial
- SleepWell24 Application
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Mayo Clinic
Lead sponsor
Arizona State University
Collaborator
Source ClinicalTrials.gov